Revefenacin (Yupelri). Yupelri (revefenacin) is a once-daily nebulized LAMA approved for the maintenance treatment of patients with COPD. It provides an option
Side Effects. Common side effects of Revefenacin include: cough; runny nose; upper respiratory tract infection; headache; back pain
Side Effects of Revefenacin (Yupelri): Cardiovascular: Hypertension Central Nervous System: Headache; Dizziness Neuromuscular Skeletal: Back Pain
Revefenacin (Yupelri). Yupelri (revefenacin) is a once-daily nebulized LAMA approved for the maintenance treatment of patients with COPD. It provides an option
clinical need for revefenacin and any potential adverse effects on the infant from revefenacin or from the Monitor for systemic anticholinergic side.
Side Effects Drug Interactions. SIDE EFFECTS. The following potential Revefenacin was negative for genotoxicity in the in vitro mouse lymphoma
Revefenacin has been reported to produce a sustained, long-acting bronchodilation with lower anti-muscarinic-related side effects. In clinical trials, revefenacin demonstrated to be of a long duration of action and low systemic exposure in patients with COPD.
Common side effects of Revefenacin include: cough; runny or stuffy nose; upper respiratory tract infection; headache; back pain
Reported side effects included headaches, shortness of breath, and coughing. The partners' decision to submit a New Drug Application for revefenacin was
Comments
one of my own pet peeves, sorry